Newborn Screening Market Size to Hit USD 1,882.59 Million by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Newborn Screening Market

5.1. COVID-19 Landscape: Newborn Screening Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Newborn Screening Market, By Product

8.1. Newborn Screening Market, by Product, 2024-2034

8.1.1 Instruments

8.1.1.1. Market Revenue and Forecast (2021-2034)

8.1.2. Reagents

8.1.2.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global Newborn Screening Market, By Technology

9.1. Newborn Screening Market, by Technology, 2024-2034

9.1.1. Tandem Mass Spectrometry

9.1.1.1. Market Revenue and Forecast (2021-2034)

9.1.2. Pulse Oximetry

9.1.2.1. Market Revenue and Forecast (2021-2034)

9.1.3. Enzyme Based Assay

9.1.3.1. Market Revenue and Forecast (2021-2034)

9.1.4. DNA Assay

9.1.4.1. Market Revenue and Forecast (2021-2034)

9.1.5. Electrophoresis

9.1.5.1. Market Revenue and Forecast (2021-2034)

9.1.6. Others

9.1.6.1. Market Revenue and Forecast (2021-2034)

Chapter 10. Global Newborn Screening Market, By Test Type

10.1. Newborn Screening Market, by Test Type, 2024-2034

10.1.1. Dry Blood Spot Test

10.1.1.1. Market Revenue and Forecast (2021-2034)

10.1.2. CCHD

10.1.2.1. Market Revenue and Forecast (2021-2034)

10.1.3. Hearing Screen

10.1.3.1. Market Revenue and Forecast (2021-2034)

Chapter 11. Global Newborn Screening Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Product (2021-2034)

11.1.2. Market Revenue and Forecast, by Technology (2021-2034)

11.1.3. Market Revenue and Forecast, by Test Type (2021-2034)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Product (2021-2034)

11.1.4.2. Market Revenue and Forecast, by Technology (2021-2034)

11.1.4.3. Market Revenue and Forecast, by Test Type (2021-2034)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Product (2021-2034)

11.1.5.2. Market Revenue and Forecast, by Technology (2021-2034)

11.1.5.3. Market Revenue and Forecast, by Test Type (2021-2034)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Product (2021-2034)

11.2.2. Market Revenue and Forecast, by Technology (2021-2034)

11.2.3. Market Revenue and Forecast, by Test Type (2021-2034)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Product (2021-2034)

11.2.4.2. Market Revenue and Forecast, by Technology (2021-2034)

11.2.4.3. Market Revenue and Forecast, by Test Type (2021-2034)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Product (2021-2034)

11.2.5.2. Market Revenue and Forecast, by Technology (2021-2034)

11.2.5.3. Market Revenue and Forecast, by Test Type (2021-2034)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Product (2021-2034)

11.2.6.2. Market Revenue and Forecast, by Technology (2021-2034)

11.2.6.3. Market Revenue and Forecast, by Test Type (2021-2034)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Product (2021-2034)

11.2.7.2. Market Revenue and Forecast, by Technology (2021-2034)

11.2.7.3. Market Revenue and Forecast, by Test Type (2021-2034)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Product (2021-2034)

11.3.2. Market Revenue and Forecast, by Technology (2021-2034)

11.3.3. Market Revenue and Forecast, by Test Type (2021-2034)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Product (2021-2034)

11.3.4.2. Market Revenue and Forecast, by Technology (2021-2034)

11.3.4.3. Market Revenue and Forecast, by Test Type (2021-2034)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Product (2021-2034)

11.3.5.2. Market Revenue and Forecast, by Technology (2021-2034)

11.3.5.3. Market Revenue and Forecast, by Test Type (2021-2034)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Product (2021-2034)

11.3.6.2. Market Revenue and Forecast, by Technology (2021-2034)

11.3.6.3. Market Revenue and Forecast, by Test Type (2021-2034)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Product (2021-2034)

11.3.7.2. Market Revenue and Forecast, by Technology (2021-2034)

11.3.7.3. Market Revenue and Forecast, by Test Type (2021-2034)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Product (2021-2034)

11.4.2. Market Revenue and Forecast, by Technology (2021-2034)

11.4.3. Market Revenue and Forecast, by Test Type (2021-2034)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Product (2021-2034)

11.4.4.2. Market Revenue and Forecast, by Technology (2021-2034)

11.4.4.3. Market Revenue and Forecast, by Test Type (2021-2034)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Product (2021-2034)

11.4.5.2. Market Revenue and Forecast, by Technology (2021-2034)

11.4.5.3. Market Revenue and Forecast, by Test Type (2021-2034)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Product (2021-2034)

11.4.6.2. Market Revenue and Forecast, by Technology (2021-2034)

11.4.6.3. Market Revenue and Forecast, by Test Type (2021-2034)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Product (2021-2034)

11.4.7.2. Market Revenue and Forecast, by Technology (2021-2034)

11.4.7.3. Market Revenue and Forecast, by Test Type (2021-2034)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Product (2021-2034)

11.5.2. Market Revenue and Forecast, by Technology (2021-2034)

11.5.3. Market Revenue and Forecast, by Test Type (2021-2034)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Product (2021-2034)

11.5.4.2. Market Revenue and Forecast, by Technology (2021-2034)

11.5.4.3. Market Revenue and Forecast, by Test Type (2021-2034)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Product (2021-2034)

11.5.5.2. Market Revenue and Forecast, by Technology (2021-2034)

11.5.5.3. Market Revenue and Forecast, by Test Type (2021-2034)

Chapter 12. Company Profiles

12.1. Bio-Rad Laboratories

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Agilent Technologies

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Waters Corporation

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Natus Medical

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Trivitron Healthcare

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. GE Lifesciences

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. PerkinElmer Inc

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. AB SCIEX

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Covidien plc

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Masimo

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global newborn screening market size is expected to grow from USD 909.18 million in 2024 to USD 1,882.59 million by 2034.

The newborn screening market is anticipated to grow at a CAGR of 7.55% between 2024 and 2034.

The major players operating in the newborn screening market are Bio-Rad Laboratories, Agilent Technologies, Waters Corporation, Natus Medical, Trivitron Healthcare, GE Lifesciences, PerkinElmer Inc, AB SCIEX, Covidien plc, Masimo, and Others.

The driving factors of the newborn screening market are the rising birth rate in developing countries and increasing public-private partnerships towards improving healthcare facilities.

Asia Pacific region will lead the global newborn screening market during the forecast period 2024 to 2034.